BioFluidica
BioFluidica has created LiquidScan an automated and flexible platform that enables cell-based and exosome-based liquid biopsy tests. LiquidScan uses microfluidic chips surfaced with specific antibodies to catch and release CTCs and exosomes from e.g., a standard blood draw that can then be subjected to specific molecular tests, based on NGS, RNA-SEQ, qPCR, ddPCR, etc., or Immuno analyses to diagnose and track disease.